|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09997 KANGJI MEDICAL
Nominal 
8.500 0.000 (0.000%) | 2022/12 - Final RMB(¥) | %Chg (Final to Final) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | 2018/12 RMB(¥) | ||
| Turnover | 786,367,000 | 13.923% | 690,263,000 | 511,490,000 | 503,467,000 | 353,670,000 | |
| Cost of Sales | (151,120,000) | 18.677% | (127,337,000) | (80,020,000) | (80,292,000) | (64,373,000) | |
| Gross Profit | 635,247,000 | 12.847% | 562,926,000 | 431,470,000 | 423,175,000 | 289,297,000 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,054,000 | -- | (614,000) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 563,144,000 | 5.360% | 534,497,000 | 310,075,000 | 391,194,000 | 261,159,000 | |
| Taxation | (101,970,000) | 31.222% | (77,708,000) | (50,925,000) | (64,459,000) | (37,366,000) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 17,561,000 | -- | 0 | (8,854,000) | (120,291,000) | (77,092,000) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 478,735,000 | 4.804% | 456,789,000 | 250,296,000 | 206,444,000 | 146,701,000 | |
| Net Finance Costs / (Income) | (68,128,000) | 105.875% | (33,092,000) | (11,735,000) | (12,560,000) | (6,956,000) | |
| Depreciation & Amortisation | 21,631,000 | 82.386% | 11,860,000 | 8,204,000 | 6,845,000 | 6,261,000 | |
| Directors' Emoluments | -- | -- | 7,756,000 | 8,204,000 | 867,000 | 631,000 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 39.630 | -- | 37.310 | 26.270 | 20.110 | -- |
| DPS (cts) | 18.450 | -- | 14.610 | 3.702 | -- | -- |
| Dividend Payout Ratio (%) | 46.556% | -- | 39.158% | 14.093% | -- | -- |
| Cash flow per share ($) | 0.264 | -- | 0.356 | 0.232 | 0.317 | -- |
| NBV per share ($) | 2.766 | -- | 2.617 | 2.345 | -- | -- |
| Remarks: | Real time quote last updated: 01/06/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 478,735,000 |
| %Change | 4.804% |
| EPS / (LPS) | RMB 0.396 |
| NBV Per Share (¥) | RMB 2.766 |